Davis Polk advised Credit Suisse Securities (USA) LLC and Cowen and Company, LLC as joint book-running managers in connection with the $82.8 million Achaogen, Inc. initial public offering, which includes the full exercise of the underwriters’ over-allotment option. Achaogen’s common stock is listed on the NASDAQ Global Market under the symbol “AKAO.” 

Based in South San Francisco, California, Achaogen is a clinical-stage biopharmaceutical company developing novel antibacterials to treat multi-drug resistant (MDR) gram-negative infections.  

The Davis Polk corporate team included partner Bruce K. Dallas and associates Jeffrey C. Lau, Emily Roberts and Brian J. Smith. The tax team included partner Rachel D. Kleinberg and associate Catherine Paskoff Chang. Associate Bruce Rose-Innes provided intellectual property advice. Counsel Cynthia Akard provided executive compensation advice. Counsel Marcie A. Goldstein provided FINRA advice. Members of the Davis Polk team are based in the Menlo Park and New York offices.